Bioengineered
Q2IF4.2SJR1.023
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 1.023 | Q1 | 84.4% | |
| 2024 | — | — | 1.051 | Q1 | 85.5% | |
| 2023 | 4.2 | Q2 | 78.6% | 0.899 | Q1 | 82.9% |
| 2022 | 4.9 | Q1 | 75.5% | 0.613 | Q2 | 72.7% |
| 2021 | 6.8 | Q1 | 88.0% | 0.600 | Q2 | 72.9% |
| 2020 | — | — | 0.518 | Q3 | 67.2% | |
| 2019 | — | — | 0.421 | Q3 | 62.5% | |
| 2018 | — | — | 0.389 | Q3 | 58.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2165-5979
ISSN
2165-5987
region
Western Europe
coverage
2012-2026